| Entry |
|
| Name |
EGF-EGFR-PI3K signaling pathway
|
| Definition |
EGF -> EGFR -> PI3K -> PIP3 -> AKT -| BAD |
| Expanded |
1950 -> 1956 -> (5290,5291,5293) -> C05981 -> (207,208,10000) -| 572 |
| Class |
|
| Type |
Reference
|
| Pathway |
|
| Gene |
| 1950 | EGF; epidermal growth factor |
| 1956 | EGFR; epidermal growth factor receptor |
| 5290 | PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
| 5291 | PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
| 5293 | PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
| 207 | AKT1; AKT serine/threonine kinase 1 |
| 208 | AKT2; AKT serine/threonine kinase 2 |
| 10000 | AKT3; AKT serine/threonine kinase 3 |
| 572 | BAD; BCL2 associated agonist of cell death |
|
| Metabolite |
| C05981 | Phosphatidylinositol-3,4,5-trisphosphate |
|
| Reference |
|
| Authors |
Cantley LC |
| Title |
The phosphoinositide 3-kinase pathway. |
| Journal |
|
| Reference |
|
| Authors |
Song G, Ouyang G, Bao S |
| Title |
The activation of Akt/PKB signaling pathway and cell survival. |
| Journal |
|
| Reference |
|
| Authors |
Hers I, Vincent EE, Tavare JM |
| Title |
Akt signalling in health and disease. |
| Journal |
|
| Reference |
|
| Authors |
Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. |
| Title |
Exploiting the PI3K/AKT pathway for cancer drug discovery. |
| Journal |
|
| LinkDB |
|